45 CFR § 180 compliance
D · 65
This hospital published part of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
○Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
2,642
Insurances with rates
0
CPT / HCPCS codes
842
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J2507 | PEGLOTICASE 8 MG/ML IV SOLN | $87,966 | $43,983 | — | — | 0 |
| J2507 | PEGLOTICASE 8 MG/ML IV SOLN | $87,966 | $43,983 | — | — | 0 |
| 99999-0101-02 | CABAZITAXEL 10 MG/ML IV SOLN (DILUTED) - COMPOUNDED | $67,907 | $33,954 | — | — | 0 |
| 99999-0101-02 | CABAZITAXEL 10 MG/ML IV SOLN (DILUTED) - COMPOUNDED | $67,907 | $33,954 | — | — | 0 |
| J9309 | POLATUZUMAB VEDOTIN-PIIQ 140 MG IV SOLR | $54,218 | $27,109 | — | — | 0 |
| J9309 | POLATUZUMAB VEDOTIN-PIIQ 140 MG IV SOLR | $54,218 | $27,109 | — | — | 0 |
| C1722 | EMBLEM MRI S-ICD | $35,640 | $17,820 | — | — | 0 |
| C1722 | EMBLEM MRI S-ICD | $35,640 | $17,820 | — | — | 0 |
| J9271 | PEMBROLIZUMAB 100 MG/4ML IV SOLN | $35,396 | $17,698 | — | — | 0 |
| J9271 | PEMBROLIZUMAB 100 MG/4ML IV SOLN | $35,396 | $17,698 | — | — | 0 |
| C1764 | CARDIAC MONITOR LUX DX INSERTABLE | $34,425 | $17,213 | — | — | 0 |
| C1764 | CARDIAC MONITOR LUX DX INSERTABLE | $34,425 | $17,213 | — | — | 0 |
| J9022 | ATEZOLIZUMAB 1200 MG/20ML IV SOLN | $32,782 | $16,391 | — | — | 0 |
| J9022 | ATEZOLIZUMAB 1200 MG/20ML IV SOLN | $32,782 | $16,391 | — | — | 0 |
| J9228 | IPILIMUMAB 50 MG/10ML IV SOLN | $26,119 | $13,060 | — | — | 0 |
| J9228 | IPILIMUMAB 50 MG/10ML IV SOLN | $26,119 | $13,060 | — | — | 0 |
| J3380 | VEDOLIZUMAB 300 MG IV SOLR | $26,010 | $13,005 | — | — | 0 |
| J3380 | VEDOLIZUMAB 300 MG IV SOLR | $26,010 | $13,005 | — | — | 0 |
| J2427 | PALIPERIDONE PALMITATE ER 546 MG/1.75ML IM SUSY | $20,883 | $10,441 | — | — | 0 |
| J2427 | PALIPERIDONE PALMITATE ER 546 MG/1.75ML IM SUSY | $20,883 | $10,441 | — | — | 0 |
| J9306 | PERTUZUMAB 420 MG/14ML IV SOLN | $19,590 | $9,795 | — | — | 0 |
| J9306 | PERTUZUMAB 420 MG/14ML IV SOLN | $19,590 | $9,795 | — | — | 0 |
| J1303 | RAVULIZUMAB-CWVZ 300 MG/3ML IV SOLN | $19,222 | $9,611 | — | — | 0 |
| J1303 | RAVULIZUMAB-CWVZ 300 MG/3ML IV SOLN | $19,222 | $9,611 | — | — | 0 |
| J9043 | CABAZITAXEL 60 MG/1.5ML IV SOLN | $16,980 | $8,490 | — | — | 0 |
| J9043 | CABAZITAXEL 60 MG/1.5ML IV SOLN | $16,980 | $8,490 | — | — | 0 |
| J1162 | DIGOXIN IMMUNE FAB 40 MG IV SOLR | $14,359 | $7,180 | — | — | 0 |
| J1162 | DIGOXIN IMMUNE FAB 40 MG IV SOLR | $14,359 | $7,180 | — | — | 0 |
| J9042 | BRENTUXIMAB VEDOTIN 50 MG IV SOLR | $14,094 | $7,047 | — | — | 0 |
| J9042 | BRENTUXIMAB VEDOTIN 50 MG IV SOLR | $14,094 | $7,047 | — | — | 0 |
| J7504 | ANTI-THYMOCYTE GLOB (EQUINE) 50 MG/ML IV INJ | $12,585 | $6,292 | — | — | 0 |
| J7504 | ANTI-THYMOCYTE GLOB (EQUINE) 50 MG/ML IV INJ | $12,585 | $6,292 | — | — | 0 |
| Q5111 | PEGFILGRASTIM-CBQV 6 MG/0.6ML SC SOSY | $12,535 | $6,268 | — | — | 0 |
| Q5111 | PEGFILGRASTIM-CBQV 6 MG/0.6ML SC SOSY | $12,535 | $6,268 | — | — | 0 |
| Q5122 | PEGFILGRASTIM-APGF 6 MG/0.6ML SC SOSY | $11,785 | $5,893 | — | — | 0 |
| Q5122 | PEGFILGRASTIM-APGF 6 MG/0.6ML SC SOSY | $11,785 | $5,893 | — | — | 0 |
| J0565 | BEZLOTOXUMAB 1000 MG/40ML IV SOLN | $11,410 | $5,705 | — | — | 0 |
| J0565 | BEZLOTOXUMAB 1000 MG/40ML IV SOLN | $11,410 | $5,705 | — | — | 0 |
| C1785 | PACEMAKER ACCOLADE MRI EL | $11,027 | $5,514 | — | — | 0 |
| C1785 | PACEMAKER ACCOLADE MRI EL | $11,027 | $5,514 | — | — | 0 |
| J2353 | OCTREOTIDE ACETATE 10 MG IM KIT | $10,580 | $5,290 | — | — | 0 |
| J2353 | OCTREOTIDE ACETATE 10 MG IM KIT | $10,580 | $5,290 | — | — | 0 |
| 00074-3799-02 | ADALIMUMAB 40 MG/0.8ML SC PSKT | $10,394 | $5,197 | — | — | 0 |
| 00074-3799-02 | ADALIMUMAB 40 MG/0.8ML SC PSKT | $10,394 | $5,197 | — | — | 0 |
| 66658-0231-01 | PALIVIZUMAB 100 MG/ML IM SOLN | $10,324 | $5,162 | — | — | 0 |
| 66658-0231-01 | PALIVIZUMAB 100 MG/ML IM SOLN | $10,324 | $5,162 | — | — | 0 |
| J0897 | DENOSUMAB 120 MG/1.7ML SC SOLN | $9,866 | $4,933 | — | — | 0 |
| J0897 | DENOSUMAB 120 MG/1.7ML SC SOLN | $9,866 | $4,933 | — | — | 0 |
| J9223 | LURBINECTEDIN 4 MG IV SOLR | $9,640 | $4,820 | — | — | 0 |
| J9223 | LURBINECTEDIN 4 MG IV SOLR | $9,640 | $4,820 | — | — | 0 |
Showing top 50 of 2,642 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.